145 related articles for article (PubMed ID: 32562045)
1. National trends in the management of patients with positive surgical margins at radical prostatectomy.
Ghabili K; Park HS; Yu JB; Sprenkle PC; Kim SP; Nguyen KA; Ma X; Gross CP; Leapman MS
World J Urol; 2021 Apr; 39(4):1141-1151. PubMed ID: 32562045
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant Androgen Deprivation Therapy Prior to Radical Prostatectomy: Recent Trends in Utilization and Association with Postoperative Surgical Margin Status.
McClintock TR; von Landenberg N; Cole AP; Lipsitz SR; Gild P; Sun M; Fletcher SA; Roghmann F; Menon M; Nguyen PL; Noldus J; Choueiri TK; Kibel AS; Trinh QD
Ann Surg Oncol; 2019 Jan; 26(1):297-305. PubMed ID: 30430324
[TBL] [Abstract][Full Text] [Related]
3. Trends and Predictors of Adjuvant Therapy for Adverse Features Following Radical Prostatectomy: An Analysis From Cancer of the Prostate Strategic Urologic Research Endeavor.
Balakrishnan AS; Zhao S; Cowan JE; Broering JM; Cooperberg MR; Carroll PR
Urology; 2019 Sep; 131():157-165. PubMed ID: 31150694
[TBL] [Abstract][Full Text] [Related]
4. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
[TBL] [Abstract][Full Text] [Related]
5. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
[TBL] [Abstract][Full Text] [Related]
6. The role of adjuvant radiotherapy in pathologically lymph node-positive prostate cancer.
Jegadeesh N; Liu Y; Zhang C; Zhong J; Cassidy RJ; Gillespie T; Kucuk O; Rossi P; Master VA; Alemozaffar M; Jani AB
Cancer; 2017 Feb; 123(3):512-520. PubMed ID: 27859018
[TBL] [Abstract][Full Text] [Related]
7. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
[TBL] [Abstract][Full Text] [Related]
8. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy.
Jackson WC; Schipper MJ; Johnson SB; Foster C; Li D; Sandler HM; Palapattu GS; Hamstra DA; Feng FY
Eur Urol; 2016 Jan; 69(1):50-7. PubMed ID: 26004800
[TBL] [Abstract][Full Text] [Related]
9. Comparative effectiveness of robot-assisted versus open radical prostatectomy cancer control.
Hu JC; Gandaglia G; Karakiewicz PI; Nguyen PL; Trinh QD; Shih YC; Abdollah F; Chamie K; Wright JL; Ganz PA; Sun M
Eur Urol; 2014 Oct; 66(4):666-72. PubMed ID: 24602934
[TBL] [Abstract][Full Text] [Related]
10. Tailored treatment including radical prostatectomy and radiation therapy + androgen deprivation therapy versus exclusive radical prostatectomy in high-risk prostate cancer patients: results from a prospective study.
Castelli T; Russo GI; Favilla V; Urzi D; Spitaleri F; Reale G; Giardina R; Saita A; Madonia M; Cimino S; Morgia G
Int Braz J Urol; 2014; 40(3):322-9. PubMed ID: 25010298
[TBL] [Abstract][Full Text] [Related]
11. Survival Outcomes of Men with Lymph Node-positive Prostate Cancer After Radical Prostatectomy: A Comparative Analysis of Different Postoperative Management Strategies.
Touijer KA; Karnes RJ; Passoni N; Sjoberg DD; Assel M; Fossati N; Gandaglia G; Eastham JA; Scardino PT; Vickers A; Cozzarini C; Montorsi F; Briganti A
Eur Urol; 2018 Jun; 73(6):890-896. PubMed ID: 29042125
[TBL] [Abstract][Full Text] [Related]
12. Positive surgical margins: rate, contributing factors and impact on further treatment: findings from the Prostate Cancer Registry.
Evans SM; Millar JL; Frydenberg M; Murphy DG; Davis ID; Spelman T; Bolton DM; Giles GG; Dean J; Costello AJ; Frauman AG; Kearns PA; Day L; Daniels C; McNeill JJ
BJU Int; 2014 Nov; 114(5):680-90. PubMed ID: 24128010
[TBL] [Abstract][Full Text] [Related]
13. Declining Use of Radiotherapy for Adverse Features After Radical Prostatectomy: Results From the National Cancer Data Base.
Sineshaw HM; Gray PJ; Efstathiou JA; Jemal A
Eur Urol; 2015 Nov; 68(5):768-74. PubMed ID: 25896124
[TBL] [Abstract][Full Text] [Related]
14. Low rates of androgen deprivation therapy use with salvage radiation therapy in patients with prostate cancer after radical prostatectomy.
Yang DD; Muralidhar V; Mahal BA; Nezolosky MD; Labe SA; Vastola ME; Boldbaatar N; King MT; Martin NE; Orio PF; Choueiri TK; Trinh QD; Den RB; Spratt DE; Hoffman KE; Feng FY; Nguyen PL
Urol Oncol; 2017 Sep; 35(9):542.e25-542.e32. PubMed ID: 28533151
[TBL] [Abstract][Full Text] [Related]
15. The impact of positive surgical margins on salvage radiation or androgen deprivation therapy following radical prostatectomy - a nationwide study.
Stroomberg HV; Friberg AS; Helgstrand JT; Brasso K; Røder MA
Acta Oncol; 2021 May; 60(5):620-626. PubMed ID: 33734927
[TBL] [Abstract][Full Text] [Related]
16. Variation in Positive Surgical Margin Status After Radical Prostatectomy for pT2 Prostate Cancer.
Tan WS; Krimphove MJ; Cole AP; Marchese M; Berg S; Lipsitz SR; Löppenberg B; Nabi J; Abdollah F; Choueiri TK; Kibel AS; Sooriakumaran P; Trinh QD
Clin Genitourin Cancer; 2019 Oct; 17(5):e1060-e1068. PubMed ID: 31303561
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant radiation with androgen-deprivation therapy for men with lymph node metastases after radical prostatectomy: identifying men who benefit.
Gupta M; Patel HD; Schwen ZR; Tran PT; Partin AW
BJU Int; 2019 Feb; 123(2):252-260. PubMed ID: 29626845
[TBL] [Abstract][Full Text] [Related]
18. Positive surgical margins at radical prostatectomy in the United States: Institutional variations and predictive factors.
Pooli A; Salmasi A; Johnson DC; Lenis AT; Faiena I; Lebacle C; Golla V; Drakaki A; Gollapudi K; Blumberg J; Pantuck AJ; Chamie K
Urol Oncol; 2020 Jan; 38(1):1.e17-1.e23. PubMed ID: 31537483
[TBL] [Abstract][Full Text] [Related]
19. Salvage radiation therapy following radical prostatectomy. A national Danish study.
Ervandian M; Høyer M; Petersen SE; Sengeløv L; Hansen S; Holmberg M; Sveistrup J; Meidahl Petersen P; Borre M
Acta Oncol; 2016 May; 55(5):598-603. PubMed ID: 26399602
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant radiotherapy in patients with node-positive prostate cancer after radical prostatectomy.
Chen H; Qu M; Shi H; Dong Z; Wang Y; Gao X
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4925-4932. PubMed ID: 36308526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
